Chirality 2013-01-01

Stereoselectivity in the salt-cocrystal products formed by phenylglycinol or phenylglycine with their respective sodium or hydrochloride salts.

Harry G Brittain

Index: Chirality 25(1) , 8-15, (2013)

Full Text: HTML

Abstract

The salt and stereoselective cocrystal phenomena associated with 2-phenylglycinol and 2-phenylglycine have been studied using X-ray powder diffraction and differential scanning calorimetry. The chiral identities of the free acids and their sodium salts, or the free bases and their chloride salts, were found to play a determining role as to whether a salt-cocrystal product could or could not be formed. In particular, when cocrystallization of an enantiomerically pure basic or zwitterionic substance with its enantiomerically pure acid addition salt was attempted, a salt-cocrystal was only obtained when the absolute configuration of the two reactants is opposite. On the other hand, it has been found that no stereoselectivity in salt-cocrystal formation existed in the cocrystallization of an enantiomerically pure acidic or zwitterionic substance with its enantiomerically pure base addition salt.Copyright © 2012 Wiley Periodicals, Inc.

Related Compounds

  • H-Phg-OH
  • 2-Anilinoethanol
  • D-2-Phenylglycine
  • 2-Phenylglycine

Related Articles:

Glyphosate suppresses the antagonistic effect of Enterococcus spp. on Clostridium botulinum.

2013-04-01

[Bioorg. Med. Chem. Lett. 16 , 1138-41, (2006)]

Two plate-based colorimetric assays for screening α-amino acid ester hydrolase with high synthesis/hydrolysis ratio.

2012-07-15

[Enzyme Microb. Technol. 51(2) , 107-12, (2012)]

Mutation-specific potency and efficacy of cystic fibrosis transmembrane conductance regulator chloride channel potentiators.

2009-09-01

[J. Pharmacol. Exp. Ther. 330(3) , 783-91, (2009)]

Design and synthesis of a hybrid potentiator-corrector agonist of the cystic fibrosis mutant protein DeltaF508-CFTR.

2010-01-01

[Bioorg. Med. Chem. Lett. 20(1) , 87-91, (2010)]

Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors.

2005-12-01

[Bioorg. Med. Chem. Lett. 15(23) , 5344-52, (2005)]

More Articles...